Commonalities and contrasts in recent guidelines for lupus anticoagulant detection

International Journal of Laboratory Hematology

Volumn 36, Issue 3, 2014, Pages 364-373

  Moore, G W ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Activated partial thromboplastin time; Dilute Russell's viper venom time; Guidelines; Lupus anticoagulants; Mixing tests

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; ELLAGIC ACID; HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID; SNAKE VENOM; THROMBOPLASTIN; VIPER VENOM;

ANTICOAGULATION; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; CONSENSUS; DABOIA RUSSELLII; DILUTE PROTHROMBIN TIME; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; INTERNATIONAL NORMALIZED RATIO; KAOLIN CLOTTING TIME; LIPID BLOOD LEVEL; PARTIAL THROMBOPLASTIN TIME; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; REFERENCE VALUE; REVIEW; RUSSELL VIPER VENOM TIME; SCREENING TEST; THROMBOCYTE COUNT; ULTRACENTRIFUGATION; BLOOD; BLOOD CLOTTING TEST; DIAGNOSTIC USE; PROCEDURES; REPRODUCIBILITY; STANDARDS;

BLOOD COAGULATION TESTS; HUMANS; LUPUS COAGULATION INHIBITOR; PRACTICE GUIDELINES AS TOPIC; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 84898677038     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12227     Document Type: Review

References (32)

1. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, de Groot PG. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009;7:1737-40.
2. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M; British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012;157:47-58.
3. Ledford-Kraemer MR, Moore GW, Bottenus R, Daniele C, de Groot PG, Exner T, Favaloro EJ, Moffat KA, Nichols WL. Laboratory Testing for the Lupus Anticoagulant. Approved guideline - first edition. CLSI document H60. Wayne, PA: Clinical and Laboratory Standards Institute; 2014 (in press).
4. Wong RCW, Favaloro EJ. A consensus approach to the formulation of guidelines for laboratory testing and reporting of antiphospholipid antibody assays. Semin Thromb Hemost 2008;34:361-72.
5. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185-90.
6. Greaves M, Cohen H, Machin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000;109:704-15.
7. Moore GW. Clinical utility of the less commonly employed assays for lupus anticoagulation detection: the evidence. J Coagul Disord 2010;2:69-79.
8. Tripodi A. Laboratory testing for lupus anticoagulants: a review of issues affecting results. Clin Chem 2007;53:1629-35.
9. Lawrie AS, Mackie IJ, Purdy G, Machin SJ. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers. Thromb Haemost 1999;81:758-62.
10. Jennings I, Mackie I, Arnout J, Preston FE. Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UK NEQAS proficiency testing programme. J Thromb Haemost 2004;2:2178-84.
11. Chantarangkul V, Tripodi A, Arbini A, Mannucci PM. Silica clotting time (SCT) as a screening and confirmatory test for the detection of the lupus anticoagulants. Thromb Res 1992;67:355-65.
12. Kumano O, Ieko M, Naito S, Yoshida M, Takahashi N. APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent. J Thromb Haemost 2012;10:2338-43.
13. Kershaw G, Suresh S, Orellana D, Nguy YM. Laboratory identification of lupus anticoagulants. Semin Thromb Hemost 2012;38:375-84.
14. Mackie IJ, Lawrie AS, Greenfield RS, Guinto ER, Machin SJ. A new lupus anticoagulant test based on dilute prothrombin time. Thromb Res 2004;114:673-4.
15. Devreese KMJ. Evaluation of a new commercial dilute prothrombin time in the diagnosis of lupus anticoagulants. Thromb Res 2008;123:404-11.
16. Moore GW. Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients. Thromb J 2007;5:12.
17. Moore GW, Smith MP, Patel Y, Savidge GF. The Activated Seven Lupus Anticoagulant (ASLA) assay: a new test for lupus anticoagulants (LAs). Evidence that some LAs are detectable only in extrinsic pathway based assays. Blood Coagul Fibrinolysis 2002;13:261-9.
18. Galli M, Borrelli G, Jacobsen EM, Marfisi RM, Finazzi G, Marchioli R, Wisløff F, Marziali S, Morboeuf O, Barbui T. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood 2007;110:1178-83.
19. Moore GW, Brown KL, Bromidge ES, Drew AJ, Ledford-Kraemer MR. Lupus anticoagulant detection: out of control? Int J Haematol 2013;35:128-36.
20. Gardiner C, Mackie IJ, Malia RG, Jones DW, Winter M, Leeming D, Taberner DA, Machin SJ, Greaves M. The importance of locally derived reference ranges and standardised calculation of dilute Russell's Viper venom time results in screening for lupus anticoagulant. Br J Haematol 2000;111:1230-5.
21. Horowitz GL, Altaie S, Boyd JC, Ceriotti F, Garg U, Horn P, Pesce A, Sine HE, Zakowski J. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory. Approved Guideline - Third Edition. CLSI document C28-A3c. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
22. Moore GW, Savidge GF. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied. Thromb Res 2006;118:523-8.
23. Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987;57:144-7.
24. Male C, Lechner K, Speiser W, Pabinger I. Transient lupus anticoagulants in children: stepwise disappearance of diagnostic features. Thromb Haemost 2000;83:174-5.
25. Thom J, Ivey L, Eikelboom J. Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant. J Thromb Haemost 2003;1:2689-91.
26. Reber G, Meijer P. In ECAT veritas? Lupus 2012;21:722-4.
27. Jacobsen EM, Wisløff F. False negative screening tests for lupus anticoagulants - an unrecognised problem? Thromb Res 1996;82:445-51.
28. Favaloro EJ, Bonar R, Zebeljan D, Kershaw G, Marsden K. Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost 2010;8:2828-31.
29. Tripodi A. To mix or not to mix in lupus anticoagulant testing? That is the question. Semin Thromb Hemost 2012;38:385-9.
30. Tripodi A, Pengo V. More on: laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost 2010;8:2828-31.
31. Chantarangkul V, Biguzzi E, Asti D, Palmucci C, Tripodi A. Laboratory diagnostic outcome applying detection criteria recommended by the Scientific and Standardization Committee of the ISTH on Lupus Anticoagulant. Thromb Haemost 2013;110:46-52.
32. van Os GM, de Laat B, Kamphuisen PW, Meijers JC, de Groot PG. Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time. J Thromb Haemost 2011;9:1657-9.